Decision support tool for Pregnancy

Surrey Memorial Hospital, Surrey, Canada
Targeting 3 different conditionsDecision support toolN/ARecruitingLed by Jessica Liauw, MDResearch Sponsored by University of British Columbia

Study Summary

This trial will test whether a decision support tool can help doctors communicate the benefits of antenatal corticosteroid treatment to patients who may deliver between 34 and 36 weeks of pregnancy.

Eligible Conditions
  • Pregnancy
  • Shared Decision Making
  • Premature Birth


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 8 months following implementation of the intervention.
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 8 months following implementation of the intervention. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The change in frequency of clinical counselling about late preterm antenatal corticosteroids.
Secondary outcome measures
The change in quality of clinical counselling about late preterm antenatal corticosteroids as assessed by the COMRADE scale.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Guideline + decision support toolExperimental Treatment1 Intervention
A decision support tool summarizing harms and benefits of late preterm antenatal corticosteroids will be integrated into the clinical practice guideline available to clinicians in the hospitals in the experimental arm.
Group II: Guideline onlyActive Control1 Intervention
Clinicians in the hospitals in the 'no-intervention' arm will have access to the standard guideline only (without the integrated decision support tool).

Find a site

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,367 Previous Clinical Trials
1,439,276 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,293 Previous Clinical Trials
25,478,839 Total Patients Enrolled
Jessica Liauw, MDPrincipal Investigator
University of British Columbia

Media Library

Antenatal Corticosteroids (Corticosteroid) Clinical Trial Eligibility Overview. Trial Name: NCT04792112 — N/A
Pregnancy Research Study Groups: Guideline + decision support tool, Guideline only
Pregnancy Clinical Trial 2023: Antenatal Corticosteroids Highlights & Side Effects. Trial Name: NCT04792112 — N/A
Antenatal Corticosteroids (Corticosteroid) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04792112 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment for this trial currently available?

"Affirmative. According to, this medical study launched on May 20th 2022 and has been actively recruiting since then. Currently, the trial is enrolling 460 patients across two distinct sites."

Answered by AI

How many people have been invited to participate in this experiment?

"Affirmative. According to, this scientific trial is actively recruiting patients since its inception on May 20th 2022; the listing was last updated on May 30th of that same year. 460 people need to be enrolled between 2 medical sites."

Answered by AI
~92 spots leftby Feb 2024